Protective measures against SARS‑CoV‑2
All practices and processes applied by the Group hospitals demonstrate our transparent commitment to continue improving the quality and safety of the care provided to our patients.
From the very first moment the first coronavirus case was identified in Greece, our hospitals responded immediately, implementing all the necessary measures to safeguard their facilities, protecting the health of their patients and employees.
Infection Control Committee
Assisted by the competent Infection Control Committee (ICC), at MITERA we apply all the approved operational rules and safety protocols, strictly taking into account the guidelines issued by the National Public Health Organization (NPHO), the Greek Ministry of Health and international organizations.
Guided by distinguished infectious disease specialists, the ICC ensures continuous updates regarding the developments with COVID-19, actively contributes in overseeing and organizing safety protocols, and remains on alert when it comes to monitoring the seamless and safe operation of the Hospital. It mainly focuses on ensuring that all the hospital departments work closely together and the staff receive continuous updates and training.
The following measures are followed at MITERA:
Entry to the hospital is only possible through checkpoints. Anyone entering MITERA Hospital (patients, visitors, staff) must wear a mask and have their temperature taken.
If someone is identified as a suspicious case, they are directed to a specially designed negative pressure room via a secure route, where they receive all the necessary medical care under high-protection conditions, or they are directed to the specially designed area (isobox-drive through) for a COVID-19 test.
Outpatient Clinic operation
The following precautionary measures have been taken to avoid overcrowding in waiting areas:
- Patient appointments are scheduled depending on the required time for the examination, so as to avoid crowding of patients in the waiting areas.
- COVID-19 testing is not required, but rather visitors must follow the personal protection measures (mask, distances, hand hygiene) and fill in a special questionnaire about COVID-19.
- For invasive procedures performed at the Outpatient Clinic, the patient must submit a COVID-19 molecular test result by a certified lab, which must have been carried out 1-3 days before the scheduled procedure.
- The safe distance of 2m between patients and the rule of 1 person per 10 sqm are observed in the waiting areas. If this is not possible due to limited space, patients are directed to another waiting area and are called when it is their turn.
- The doctor’s offices are adequately ventilated, preferably naturally. Where natural ventilation is not possible, the air is renewed through central air conditioning units, in accordance with the instructions in the Ministry of Health circular with ref. no. Δ1(δ)/ΓΠ οικ. 26635.
- As soon as the patients leave, all surfaces and medical equipment used during the exam are cleaned/disinfected, as per the approved guidelines issued by the Infection Control Committee.
- Instructions for visitors and patients are posted in various spots throughout the hospital.
- Only one parent per child is permitted during visits to the regular clinics of the Children’s Hospital, unless the child is under three, in which case they may be accompanied by both parents.
Results from real-time PCR or antigen detection tests performed at certified labs outside MITERA are acceptable, provided they are within the time limit required per case.
Self tests are NOT acceptable.
Τhe Infection Control Committee ensures continuous updates regarding the developments with COVID-19, actively contributes in overseeing and organizing safety protocols, and remains on alert when it comes to monitoring the seamless and safe operation of the Hospital.
As per the National Public Health Organization (NPHO) guidelines, visits to patients are prohibited. Exceptions are made in special cases and with written approval by the attending physician. In this case, only one visitor per hospitalized patient is permitted.
- Carers/visitors must have had a real-time PCR molecular test performed 48 hours before the patient’s admission.
- In emergencies requiring the presence of a carer, both an antigen and a real-time PCR molecular test are performed.
- For long hospitalizations requiring constant presence of a carer next to the patient, a real-time PCR molecular test is performed every 7 days.
- Carers leaving MITERA for more than 24 hours must produce a negative same-day antigen test upon their return.
- No visitors are allowed in the ICU.
Maternity / Children’s Hospital
Two carers are permitted for children under three and can take turns.
In emergency admissions to the Children’s Hospital, both an antigen and a real-time PCR molecular test are performed on the carer.
In the Neonatal Intensive Care Unit (NICU), visiting long-term hospitalized neonates is permitted once a week, upon display of a negative real-time PCR test from the last 48 hours. Neonates can only be breastfed or fed by mothers who are hospitalized and have undergone a real-time PCR molecular test. Mothers who are not hospitalized and whose neonates are being discharged in the next 1-2 days are trained on how to care for their babies (breastfeeding, feeding). Real-time PCR test within the last 48 hours is required for entry to the NICU.
In the Pediatric Cardiac Surgery Intensive Care Unit, visiting long-term hospitalized neonates/children is permitted once a week, upon display of a negative real-time PCR test from the last 48 hours.
Our key priority at MITERA is to provide quality services to safeguard the health of our patients.
Our key priority at HYGEIA Group is to provide quality services to safeguard the health of our patients.
Measures for patients
- Real-time PCR molecular testing within the last 72 hours is required for admission and surgical procedures (anesthesia, sedation, local anesthesia). The molecular test is repeated every 7 days for long hospitalizations.
- For any surgical, interventional or diagnostic procedure during a patient’s hospitalization, the real-time PCR molecular test is repeated if more than 72 hours have passed from the previous test.
- For patient transfers to the ICU, a new real-time PCR molecular test is required.
- For patients brought in by state ambulance or transferred from another hospital, a molecular test is performed upon admission, 5 days later and every 7 days after that.
- For all types of admissions involving oncology patients, a real-time PCR molecular test within the last 72 hours is required beforehand.
- At the One-Day Treatment Unit and the Radiotherapy & Oncology Center, a real-time PCR molecular test is required every 14 days or when symptoms appear.
- At the Hemodialysis Unit, a COVID-19 questionnaire is filled in and all patients undergo antigen testing once a week. If symptoms appear, a real-time PCR molecular test is performed before the start of the session.
- In emergencies (emergency interventional exams, surgical procedures, deliveries) a sample is collected for COVID-19 testing. The patients are treated as if they are positive and all the protective measures are followed.
Measures for staff
With a deep sense of responsibility for medical, nursing and administrative staff, patients and society on general, and taking into account the epidemiological data, the following apply:
- A negative real-time PCR molecular test is required upon returning to work after more than 4 days of absence or leave.
- An antigen test is performed once a week on all employees.
- Employees displaying symptoms DO NOT come to work and DO NOT stay at work until the result has been issued. In the event of a positive result, the Infection Control Committee guidelines are followed.
- The infection control team monitors and records the compliance of the entire staff, based on the strictest protective measures against infections.
How is the test for the SARS-CoV-2 coronavirus performed?
The outbreak of the SARS-CoV-2 pandemic placed the A-Lab, the HHG Molecular Biology and Genetics Center, at the front line of the fight against the coronavirus. Responding to the needs of all Group hospitals, the A-Lab immediately proceeded with providing molecular detection of the new virus strain, the only method that offers a fast and reliable result.
All specimens collected at the Group hospitals are treated as potentially infectious and, consequently, all the necessary separate personal protection and spread prevention measures are applied throughout the processes of collection, packaging, storage and transfer of specimens, as specified by the National Public Health Organization (NPHO), the Greek Ministry of Health and international organizations.
Real Time RT-PCR Method
Once the specimens are received by the lab, the viral RNA is isolated and polymerase chain reaction with reverse transcription is applied to amplify 2 different targets of the SARS-CoV-2 viral genome. The test is concluded within 3 to 4 hours from the time the specimens are received by the lab.
Find out more about SARS-CoV-2 coronavirus testing here
When tests are performed (real-time PCR molecular testing / antigen detection)
Real-time PCR molecular testing within 72 hours before the medical procedure is required in the following cases:
Gastroscopy, spirometry, intraesophageal ultrasound, anesthesia on imaging department outpatients (radiology, CT, MRI, Breast Center), rhinolaryngoscopy, port-a-cath.
Antigen detection within 24 hours before the exam is required in the following cases:
Children’s Hospital Emergency Department, Adult Emergency Department, Check-up Department, Imaging Departments, short hospitalizations (as an outpatient), colposcopy with biopsy, stress echo, exercise bike.
Results from real-time PCR or antigen detection tests performed at certified labs outside MITERA are accepted, provided they are within the time limit required per case.
Self tests are NOT acceptable.